AIM Executive Director Bens Testifies at PDUFA Meeting

​AIM’s Executive Director Cynthia Bens was invited by the U.S. Food and Drug Administration to participate on the patient advocacy panel during a July 15 meeting on reauthorization of the prescription drug user fee program  (PDUFA). At the meeting, Bens offered her support for PDUFA and gave several suggestions for making the renewal of the program even more effective for advancing theraputic research and development. To read her testimony, please go here.